{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T03:03:17Z","timestamp":1793674997459,"version":"4.5.1"},"reference-count":224,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100010950","name":"Department of Science and Technology of Henan Province","doi-asserted-by":"publisher","award":["242102311198"],"award-info":[{"award-number":["242102311198"]}],"id":[{"id":"10.13039\/501100010950","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006407","name":"Henan Province Natural Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82303343"],"award-info":[{"award-number":["82303343"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82101385"],"award-info":[{"award-number":["82101385"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019091","name":"Key Research and Development Program of Hunan Province of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019091","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.jconrel.2025.02.029","type":"journal-article","created":{"date-parts":[[2025,2,17]],"date-time":"2025-02-17T05:39:54Z","timestamp":1739770794000},"page":"664-685","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Tolerogenic nanovaccines for the treatment of type I allergic diseases"],"prefix":"10.1016","volume":"380","author":[{"given":"Yuxuan","family":"Ren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daoke","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lixia","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangjie","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wengjing","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ningjing","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fazhan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2025.02.029_bb0005","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.add2563","article-title":"Allergy: mechanistic insights into new methods of prevention and therapy","volume":"15","author":"Akdis","year":"2023","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jconrel.2025.02.029_bb0010","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/s41577-024-01043-3","article-title":"Single-cell analysis in rheumatic and allergic diseases: insights for clinical practice","volume":"24","author":"Nishide","year":"2024","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2025.02.029_bb0015","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1038\/s41392-023-01344-4","article-title":"Pathogenesis of allergic diseases and implications for therapeutic interventions","volume":"8","author":"Wang","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.jconrel.2025.02.029_bb0020","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1111\/all.15807","article-title":"Global, regional, and national burden of allergic disorders and their risk factors in 204 countries and territories, from 1990 to 2019: a systematic analysis for the global burden of disease study 2019","volume":"78","author":"Shin","year":"2023","journal-title":"Allergy"},{"key":"10.1016\/j.jconrel.2025.02.029_bb0025","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1111\/all.14046","article-title":"Allergic rhinitis and allergic sensitisation are still increasing among Danish adults","volume":"75","author":"Leth-M\u00f8ller","year":"2020","journal-title":"Allergy"},{"key":"10.1016\/j.jconrel.2025.02.029_bb0030","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/nri.2017.39","article-title":"Early life factors that affect allergy development","volume":"17","author":"Reynolds","year":"2017","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2025.02.029_bb0035","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1111\/all.14177","article-title":"The need for clean air: the way air pollution and climate change affect allergic rhinitis and asthma","volume":"75","author":"Eguiluz-Gracia","year":"2020","journal-title":"Allergy"},{"key":"10.1016\/j.jconrel.2025.02.029_bb0040","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s11882-024-01149-7","article-title":"Lifestyle changes and industrialization in the development of allergic diseases","volume":"24","author":"Ozdemir","year":"2024","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.1016\/j.jconrel.2025.02.029_bb0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41572-018-0001-z","article-title":"Atopic dermatitis","volume":"4","author":"Weidinger","year":"2018","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.jconrel.2025.02.029_bb0050","doi-asserted-by":"crossref","first-page":"17099","DOI":"10.1038\/nrdp.2017.99","volume":"4","author":"Food allergy","year":"2018","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.jconrel.2025.02.029_bb0055","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.immuni.2023.03.015","article-title":"Modes of type 2 immune response initiation","volume":"56","author":"Kopp","year":"2023","journal-title":"Immunity"},{"key":"10.1016\/j.jconrel.2025.02.029_bb0060","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1111\/imcb.12387","article-title":"Dendritic cells in Th2 immune responses and allergic sensitization","volume":"98","author":"Lamiable","year":"2020","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.jconrel.2025.02.029_bb0065","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/nri2262","article-title":"Treatment strategies for allergy and asthma","volume":"8","author":"Holgate","year":"2008","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2025.02.029_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.mam.2021.100995","article-title":"Cellular and molecular mechanisms of allergic asthma","volume":"85","author":"Koml\u00f3si","year":"2022","journal-title":"Mol. Asp. Med."},{"key":"10.1016\/j.jconrel.2025.02.029_bb0075","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1111\/j.1398-9995.2011.02589.x","article-title":"Immunological mechanisms of allergen-specific immunotherapy","volume":"66","author":"Jutel","year":"2011","journal-title":"Allergy"},{"key":"10.1016\/j.jconrel.2025.02.029_bb0080","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/s41565-020-00810-2","article-title":"Inducing immune tolerance with dendritic cell-targeting nanomedicines","volume":"16","author":"Cifuentes-Rius","year":"2021","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.jconrel.2025.02.029_bb0085","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/6012053","article-title":"Immunological mechanisms in allergic diseases and allergen tolerance: the role of Treg cells","volume":"2018","author":"Calzada","year":"2018","journal-title":"J Immunol Res"},{"key":"10.1016\/j.jconrel.2025.02.029_bb0090","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.add2563","article-title":"Allergy: mechanistic insights into new methods of prevention and therapy","volume":"15","author":"Akdis","year":"2023","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jconrel.2025.02.029_bb0095","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.1111\/all.14848","article-title":"Medical algorithm: diagnosis and treatment of local allergic rhinitis","volume":"76","author":"Eguiluz-Gracia","year":"2021","journal-title":"Allergy"},{"key":"10.1016\/j.jconrel.2025.02.029_bb0100","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1016\/S0140-6736(00)78276-6","article-title":"Prophylactic inoculation against hay fever","volume":"177","author":"Noon","year":"1911","journal-title":"Lancet"},{"key":"10.1016\/j.jconrel.2025.02.029_bb0105","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1084\/jem.20032058","article-title":"Immune responses in healthy and allergic individuals are characterized by a fine balance between allergen-specific T regulatory 1 and T helper 2 cells","volume":"199","author":"Akdis","year":"2004","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jconrel.2025.02.029_bb0110","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/s41587-021-00880-0","article-title":"mRNA vaccines take on immune tolerance","volume":"39","author":"Wardell","year":"2021","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jconrel.2025.02.029_bb0115","doi-asserted-by":"crossref","first-page":"609","DOI":"10.4049\/jimmunol.2200463","article-title":"Complete Tolerogenic adjuvant stimulates regulatory T cell response to immunization","volume":"210","author":"Zheng","year":"2023","journal-title":"J. Immunol."},{"key":"10.1016\/j.jconrel.2025.02.029_bb0120","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.ymthe.2021.02.003","article-title":"A Tolerizing mRNA vaccine against autoimmunity?","volume":"29","author":"Furlan","year":"2021","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2025.02.029_bb0125","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abo5284","article-title":"Tolerogenic nanoparticles induce type II collagen\u2013specific regulatory T cells and ameliorate osteoarthritis","volume":"8","author":"Sohn","year":"2022","journal-title":"Sci. Adv."},{"key":"10.1016\/j.jconrel.2025.02.029_bb0130","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.it.2020.11.001","article-title":"Tolerogenic dendritic cells in autoimmunity and inflammatory diseases","volume":"42","author":"Morante-Palacios","year":"2021","journal-title":"Trends Immunol."},{"key":"10.1016\/j.jconrel.2025.02.029_bb0135","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/s41392-022-01208-3","article-title":"Proximity-enabled covalent binding of IL-2 to IL-2R\u03b1 selectively activates regulatory T cells and suppresses autoimmunity","volume":"8","author":"Zhang","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.jconrel.2025.02.029_bb0140","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.jconrel.2024.01.018","article-title":"Transdermally delivered tolerogenic nanoparticles induced effective immune tolerance for asthma treatment","volume":"366","author":"Zhao","year":"2024","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.02.029_bb0145","doi-asserted-by":"crossref","first-page":"5229","DOI":"10.2147\/IJN.S210546","article-title":"Induction of antigen-specific immune tolerance using biodegradable nanoparticles containing antigen and dexamethasone","volume":"14","author":"Kim","year":"2019","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2025.02.029_bb0150","doi-asserted-by":"crossref","first-page":"4778","DOI":"10.1021\/acsnano.9b01444","article-title":"Use of polymeric nanoparticle platform targeting the liver to induce Treg-mediated antigen-specific immune tolerance in a pulmonary allergen sensitization model","volume":"13","author":"Liu","year":"2019","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2025.02.029_bb0155","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1021\/acsnano.0c09206","article-title":"Antigen- and epitope-delivering nanoparticles targeting liver induce comparable Immunotolerance in allergic airway disease and anaphylaxis as nanoparticle-delivering pharmaceuticals","volume":"15","author":"Liu","year":"2021","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2025.02.029_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2021.101370","article-title":"Use of a liver-targeting nanoparticle platform to intervene in peanut-induced anaphylaxis through delivery of an Ara h2 T-cell epitope","volume":"42","author":"Liu","year":"2022","journal-title":"Nano Today"},{"key":"10.1016\/j.jconrel.2025.02.029_bb0165","doi-asserted-by":"crossref","first-page":"4942","DOI":"10.1021\/acsnano.2c12420","article-title":"Use of a liver-targeting immune-Tolerogenic mRNA lipid nanoparticle platform to treat Peanut-induced anaphylaxis by single- and multiple-epitope nucleotide sequence delivery","volume":"17","author":"Xu","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2025.02.029_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.109740","article-title":"Therapeutic potential of tolerance-based peptide vaccines in autoimmune diseases","volume":"116","author":"Yu","year":"2023","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.jconrel.2025.02.029_bb0175","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.657768","article-title":"Emerging therapeutics for immune tolerance: Tolerogenic vaccines, T cell therapy, and IL-2 therapy","volume":"12","author":"Moorman","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2025.02.029_bb0180","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/8060375","article-title":"Peptide-based vaccination therapy for rheumatic diseases","volume":"2020","author":"Wang","year":"2020","journal-title":"J Immunol Res"},{"key":"10.1016\/j.jconrel.2025.02.029_bb0185","doi-asserted-by":"crossref","first-page":"9652","DOI":"10.1073\/pnas.1813461115","article-title":"Building immune tolerance through DNA vaccination","volume":"115","author":"Parks","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jconrel.2025.02.029_bb0190","article-title":"Tolerogenic Nano\u2212\/microparticle vaccines for immunotherapy","author":"Liu","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2025.02.029_bb0195","article-title":"mRNA nanomedicine: design and recent applications","volume":"2","author":"Kubiatowicz","year":"2022","journal-title":"Exploration (Beijing)"},{"key":"10.1016\/j.jconrel.2025.02.029_bb0200","doi-asserted-by":"crossref","DOI":"10.1002\/bmm2.12060","article-title":"Antigen-specific mRNA lipid nanoparticle platforms for the prevention and treatment of allergy and autoimmune diseases","volume":"2","author":"Yim","year":"2024","journal-title":"BMEMat"},{"key":"10.1016\/j.jconrel.2025.02.029_bb0205","doi-asserted-by":"crossref","first-page":"563","DOI":"10.3390\/pharmaceutics11110563","article-title":"Transcutaneous delivery of Immunomodulating pollen extract-galactomannan conjugate by solid-in-oil Nanodispersions for Pollinosis immunotherapy","volume":"11","author":"Kong","year":"2019","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2025.02.029_bb0210","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1007\/s12026-023-09445-6","article-title":"An epicutaneous therapeutic pollen-allergen extract delivery system in an allergic rhinitis mouse model: based on allergen loading on DC-specific aptamers conjugated nanogolds","volume":"72","author":"Pordel","year":"2024","journal-title":"Immunol. Res."},{"key":"10.1016\/j.jconrel.2025.02.029_bb0215","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1016\/j.jaci.2018.01.042","article-title":"Nanoemulsion adjuvant-driven redirection of T(H)2 immunity inhibits allergic reactions in murine models of peanut allergy","volume":"141","author":"O\u2019Konek","year":"2018","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.jconrel.2025.02.029_bb0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2016.01.047","article-title":"Investigation of peanut oral immunotherapy with CpG\/peanut nanoparticles in a murine model of peanut allergy","volume":"138","author":"Srivastava","year":"2016","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.jconrel.2025.02.029_bb0225","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.ijpharm.2019.03.040","article-title":"Evaluation of size and dose effects of rChe a 3 allergen loaded PLGA nanoparticles on modulation of Th2 immune responses by sublingual immunotherapy in mouse model of rhinitis allergic","volume":"563","author":"Hajavi","year":"2019","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2025.02.029_bb0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119403","article-title":"Dc-specific aptamer decorated gold nanoparticles: a new attractive insight into the nanocarriers for allergy epicutaneous immunotherapy","volume":"584","author":"Koushki","year":"2020","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2025.02.029_bb0235","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.jconrel.2022.03.016","article-title":"Development of allergic rhinitis immunotherapy using antigen-loaded small extracellular vesicles","volume":"345","author":"Liu","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.02.029_bb0240","doi-asserted-by":"crossref","first-page":"12004","DOI":"10.1021\/acsnano.8b04314","article-title":"A chromatin-mimetic nanomedicine for therapeutic tolerance induction","volume":"12","author":"Li","year":"2018","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2025.02.029_bb0245","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1007\/s10753-020-01181-5","article-title":"A20-OVA nanoparticles inhibit allergic asthma in a murine model","volume":"43","author":"Luo","year":"2020","journal-title":"Inflammation"},{"key":"10.1016\/j.jconrel.2025.02.029_bb0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2023.122381","article-title":"Safe and efficient oral allergy immunotherapy using one-pot-prepared mannan-coated allergen nanoparticles","volume":"303","author":"Li","year":"2023","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2025.02.029_bb0255","doi-asserted-by":"crossref","first-page":"2930","DOI":"10.1007\/s13346-024-01632-8","article-title":"Impact of antigen loading in tolerogenic nanoparticles to mitigate Th2-mediated allergic lung inflammation","volume":"14","author":"Scotland","year":"2024","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.jconrel.2025.02.029_bb0260","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1016\/j.jaci.2022.06.022","article-title":"Targeting CD22 on memory B cells to induce tolerance to peanut allergens","volume":"150","author":"Hardy","year":"2022","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.jconrel.2025.02.029_bb0265","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/all.15897","article-title":"Influence of antigen density and TLR ligands on preclinical efficacy of a VLP-based vaccine against peanut allergy","volume":"79","author":"Krenger","year":"2024","journal-title":"Allergy"},{"key":"10.1016\/j.jconrel.2025.02.029_bb0270","doi-asserted-by":"crossref","DOI":"10.1016\/j.waojou.2021.100522","article-title":"Chimeric antigen-guiding extracellular vesicles eliminate antigen-specific Th2 cells in subjects with food allergy","volume":"14","author":"Zhang","year":"2021","journal-title":"World Allergy Organiz. J."},{"key":"10.1016\/j.jconrel.2025.02.029_bb0275","article-title":"Allergen-encapsulating nanoparticles reprogram pathogenic allergen-specific Th2 cells to suppress food allergy","volume":"n\/a","author":"Saunders","year":"2024","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.jconrel.2025.02.029_bb0280","doi-asserted-by":"crossref","first-page":"7053","DOI":"10.2147\/IJN.S215415","article-title":"Co-delivery of allergen epitope fragments and R848 inhibits food allergy by inducing tolerogenic dendritic cells and regulatory T cells","volume":"14","author":"Hong","year":"2019","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2025.02.029_bb0285","article-title":"Oral pretreatment with \u03b2-lactoglobulin derived peptide and CpG co-encapsulated in PLGA nanoparticles prior to sensitizations attenuates cow\u2019s milk allergy development in mice","volume":"13","author":"Liu","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2025.02.029_bb0290","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1111\/imcb.12347","article-title":"Specific antigen-guiding exosomes inhibit food allergies by inducing regulatory T cells","volume":"98","author":"Yu","year":"2020","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.jconrel.2025.02.029_bb0295","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2020.155176","article-title":"Exosomes carry IL-10 and antigen\/MHC II complexes to induce antigen-specific oral tolerance","volume":"133","author":"Zeng","year":"2020","journal-title":"Cytokine"},{"key":"10.1016\/j.jconrel.2025.02.029_bb0300","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1111\/all.14064","article-title":"Intranasal nanoemulsion vaccine confers long-lasting immunomodulation and sustained unresponsiveness in a murine model of milk allergy","volume":"75","author":"O'Konek","year":"2020","journal-title":"Allergy"},{"key":"10.1016\/j.jconrel.2025.02.029_bb0305","doi-asserted-by":"crossref","first-page":"4043","DOI":"10.1038\/s41598-019-40114-7","article-title":"Glycosylated nanostructures in sublingual immunotherapy induce long-lasting tolerance in LTP allergy mouse model","volume":"9","author":"Rodriguez","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2025.02.029_bb0310","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27030598","article-title":"Effects of rAmb a 1-loaded PLGA-PEG nanoparticles in a murine model of allergic conjunctivitis","volume":"27","author":"Cao","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.jconrel.2025.02.029_bb0315","first-page":"4925","article-title":"Der p2-A20 DNA vaccine attenuates allergic inflammation in mice with allergic rhinitis","volume":"20","author":"Hu","year":"2019","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.jconrel.2025.02.029_bb0320","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.anai.2014.08.015","article-title":"Intranasal immunization with DNA vaccine coexpressing Der p 1 and ubiquitin in an allergic rhinitis mouse model","volume":"113","author":"Ou","year":"2014","journal-title":"Ann. Allergy Asthma Immunol."},{"key":"10.1016\/j.jconrel.2025.02.029_bb0325","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/7385","article-title":"Oral gene delivery with chitosan\u2013DNA nanoparticles generates immunologic protection in a murine model of peanut allergy","volume":"5","author":"Roy","year":"1999","journal-title":"Nat. Med."},{"key":"10.1016\/j.jconrel.2025.02.029_bb0330","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0014-5793(74)80813-6","article-title":"Entrapment of proteins in liposomes prevents allergic reactions in pre-immunised mice","volume":"45","author":"Gregoriadis","year":"1974","journal-title":"FEBS Lett."},{"key":"10.1016\/j.jconrel.2025.02.029_bb0335","first-page":"118","article-title":"Immunotherapy with allergen sequestered in liposomes","volume":"73","author":"Wagner","year":"1984","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.jconrel.2025.02.029_bb0340","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1084\/jem.178.5.1783","article-title":"Inhibition of T cell and antibody responses to house dust mite allergen by inhalation of the dominant T cell epitope in naive and sensitized mice","volume":"178","author":"Hoyne","year":"1993","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jconrel.2025.02.029_bb0345","doi-asserted-by":"crossref","first-page":"5141","DOI":"10.1073\/pnas.93.10.5141","article-title":"Preferential induction of a Th1 immune response and inhibition of specific IgE antibody formation by plasmid DNA immunization","volume":"93","author":"Raz","year":"1996","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.jconrel.2025.02.029_bb0350","doi-asserted-by":"crossref","first-page":"15107","DOI":"10.1128\/JVI.79.24.15107-15113.2005","article-title":"Humoral and cellular immune response to RNA immunization with Flavivirus replicons derived from tick-borne encephalitis virus","volume":"79","author":"Aberle","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.jconrel.2025.02.029_bb0355","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2009.06.036","article-title":"Immunize and disappear-safety-optimized mRNA vaccination with a panel of 29 allergens","volume":"124","author":"Roesler","year":"2009","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.jconrel.2025.02.029_bb0360","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1016\/j.jaci.2006.01.040","article-title":"Der p 1 peptide on virus-like particles is safe and highly immunogenic in healthy adults","volume":"117","author":"K\u00fcndig","year":"2006","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.jconrel.2025.02.029_bb0365","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1365-2567.2008.02812.x","article-title":"Serum-derived exosomes from antigen-fed mice prevent allergic sensitization in a model of allergic asthma","volume":"125","author":"Almqvist","year":"2008","journal-title":"Immunology"},{"key":"10.1016\/j.jconrel.2025.02.029_bb0370","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2022.121457","article-title":"Mechanistic contributions of Kupffer cells and liver sinusoidal endothelial cells in nanoparticle-induced antigen-specific immune tolerance","volume":"283","author":"Casey","year":"2022","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2025.02.029_bb0375","article-title":"Immune checkpoint ligand bioengineered Schwann cells as antigen-specific therapy for experimental autoimmune encephalomyelitis","volume":"34","author":"Au","year":"2022","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2025.02.029_bb0380","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/nature16962","article-title":"Expanding antigen-specific regulatory networks to treat autoimmunity","volume":"530","author":"Clemente-Casares","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2025.02.029_bb0385","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2021.101307","article-title":"Restoring immunological tolerance in established experimental arthritis by combinatorial citrullinated peptides and immunomodulatory signals","volume":"41","author":"Chen","year":"2021","journal-title":"Nano Today"},{"key":"10.1016\/j.jconrel.2025.02.029_bb0390","doi-asserted-by":"crossref","first-page":"2307366","DOI":"10.1002\/smll.202307366","article-title":"Transdermal microneedles alleviated rheumatoid arthritis by inducing immune tolerance via skin-resident antigen presenting cells","volume":"20","author":"Zhao","year":"2024","journal-title":"Small"},{"key":"10.1016\/j.jconrel.2025.02.029_bb0395","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jconrel.2022.08.020","article-title":"From vaccines to nanovaccines: a promising strategy to revolutionize rheumatoid arthritis treatment","volume":"350","author":"Zhang","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.02.029_bb0400","doi-asserted-by":"crossref","first-page":"19990","DOI":"10.1021\/acsnano.1c07538","article-title":"In vivo bioengineering of Beta cells with immune checkpoint ligand as a treatment for early-onset type 1 diabetes mellitus","volume":"15","author":"Au","year":"2021","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2025.02.029_bb0405","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1038\/s41551-021-00738-5","article-title":"Induction of antigen-specific tolerance by nanobody-antigen adducts that target class-II major histocompatibility complexes","volume":"5","author":"Pishesha","year":"2021","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.jconrel.2025.02.029_bb0410","doi-asserted-by":"crossref","first-page":"4414","DOI":"10.1021\/acsnano.9b09998","article-title":"MicroRNA-125a-loaded polymeric nanoparticles alleviate systemic lupus erythematosus by restoring effector\/regulatory T cells balance","volume":"14","author":"Zhang","year":"2020","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2025.02.029_bb0415","first-page":"632","article-title":"Suppression of murine lupus by CD4+ and CD8+ Treg cells induced by T cell-targeted nanoparticles loaded with Interleukin-2 and transforming growth factor \u03b2, arthritis","volume":"71","author":"Horwitz","year":"2019","journal-title":"Rheumatol"},{"key":"10.1016\/j.jconrel.2025.02.029_bb0420","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1021\/acs.nanolett.0c05110","article-title":"Nanoemulsions target to ectopic Lymphoids in inflamed joints to restore immune tolerance in rheumatoid arthritis","volume":"21","author":"Li","year":"2021","journal-title":"Nano Lett."},{"key":"10.1016\/j.jconrel.2025.02.029_bb0425","article-title":"Transdermal microneedles alleviated rheumatoid arthritis by inducing immune tolerance via skin-resident antigen presenting cells","volume":"20","author":"Zhao","year":"2023","journal-title":"Small"},{"key":"10.1016\/j.jconrel.2025.02.029_bb0430","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.160964","article-title":"Randomized phase I trial of antigen-specific tolerizing immunotherapy with peptide\/calcitriol liposomes in ACPA+ rheumatoid arthritis","volume":"7","author":"Sonigra","year":"2022","journal-title":"JCI Insight"},{"key":"10.1016\/j.jconrel.2025.02.029_bb0435","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1136\/annrheumdis-2015-208456","article-title":"Autologous tolerogenic dendritic cells for rheumatoid and inflammatory arthritis","volume":"76","author":"Bell","year":"2017","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jconrel.2025.02.029_bb0440","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaa9301","article-title":"Citrullinated peptide dendritic cell immunotherapy in HLA risk genotype-positive rheumatoid arthritis patients","volume":"7","author":"Benham","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jconrel.2025.02.029_bb0445","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.106525","article-title":"Immune responses modulation by curcumin and allergen encapsulated into PLGA nanoparticles in mice model of rhinitis allergic through sublingual immunotherapy","volume":"84","author":"Shahgordi","year":"2020","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.jconrel.2025.02.029_bb0450","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.jconrel.2021.05.048","article-title":"Chitosan-centered nanosystems as sustained therapeutics for allergic rhinitis intervention: inhibition of histamine-induced cascades","volume":"335","author":"Sun","year":"2021","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.02.029_bb0455","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1159\/000512872","article-title":"A dendritic cells-targeting Nano-vaccine by coupling Polylactic-co-glycolic acid-encapsulated allergen with Mannan induces regulatory T cells","volume":"182","author":"Wen","year":"2021","journal-title":"Int. Arch. Allergy Immunol."},{"key":"10.1016\/j.jconrel.2025.02.029_bb0460","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.676558","article-title":"A component-resolved therapeutic vaccine for cockroach allergy made of per a 9 and transforming growth factor-\u03b2 homologue, an immunosuppressive protein of Brugia malayi","volume":"12","author":"Prangtaworn","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2025.02.029_bb0465","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.599296","article-title":"Mucosal Nanoemulsion allergy vaccine suppresses Alarmin expression and induces bystander suppression of reactivity to multiple food allergens","volume":"12","author":"Farazuddin","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2025.02.029_bb0470","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejpb.2024.114242","article-title":"Tailoring lipid nanoparticles for T-cell targeting in allergic asthma: insights into efficacy and specificity","volume":"198","author":"J\u00fcrgens","year":"2024","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2025.02.029_bb0475","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.jconrel.2020.07.021","article-title":"Silica nanoparticles: a promising platform for enhanced oral delivery of macromolecules","volume":"326","author":"Abeer","year":"2020","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.02.029_bb0480","article-title":"Reducing the solubility of the major birch pollen allergen bet v 1 by particle-loading mitigates Th2 responses","author":"Kraiem","year":"2024","journal-title":"Allergol. Int."},{"key":"10.1016\/j.jconrel.2025.02.029_bb0485","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2023.113715","article-title":"Facile fabrication of diatomite biosilica-based nasal drug delivery vehicle for enhanced treatment of allergic rhinitis","volume":"234","author":"Peng","year":"2024","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.jconrel.2025.02.029_bb0490","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jphotobiol.2018.12.015","article-title":"Biosynthesis of gold nanoparticles using Caffeoylxanthiazonoside, chemical isolated from Xanthium strumarium L. fruit and their anti-allergic rhinitis effect- a traditional Chinese medicine","volume":"192","author":"Peng","year":"2019","journal-title":"J. Photochem. Photobiol. B"},{"key":"10.1016\/j.jconrel.2025.02.029_bb0495","article-title":"Recent applications of immunomodulatory biomaterials for disease immunotherapy","volume":"2","author":"Dai","year":"2022","journal-title":"Exploration (Beijing)"},{"key":"10.1016\/j.jconrel.2025.02.029_bb0500","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119403","article-title":"Dc-specific aptamer decorated gold nanoparticles: a new attractive insight into the nanocarriers for allergy epicutaneous immunotherapy","volume":"584","author":"Koushki","year":"2020","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2025.02.029_bb0505","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1429442","article-title":"Immunomodulatory effect of PLGA-encapsulated mesenchymal stem cells-derived exosomes for the treatment of allergic rhinitis","volume":"15","author":"Shahzad","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2025.02.029_bb0510","first-page":"32","article-title":"Future directions of allergen immunotherapy for allergic rhinitis: Experts\u2019 perspective, the journal of allergy and clinical immunology","volume":"12","author":"Pfaar","year":"2024","journal-title":"In Pract."},{"key":"10.1016\/j.jconrel.2025.02.029_bb0515","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/cea.14261","article-title":"From trained immunity in allergy to trained immunity-based allergen vaccines","volume":"53","author":"Mart\u00edn-Cruz","year":"2023","journal-title":"Clin. Exp. Allergy"},{"key":"10.1016\/j.jconrel.2025.02.029_bb0520","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.iac.2011.03.001","article-title":"Adjuvants and vector systems for allergy vaccines","volume":"31","author":"Moingeon","year":"2011","journal-title":"Immunol. Allergy Clin. N. Am."},{"key":"10.1016\/j.jconrel.2025.02.029_bb0525","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1097\/ACI.0000000000000772","article-title":"Nucleic acid vaccines and CpG oligodeoxynucleotides for allergen immunotherapy","volume":"21","author":"Jacquet","year":"2021","journal-title":"Curr. Opin. Allergy Clin. Immunol."},{"key":"10.1016\/j.jconrel.2025.02.029_bb0530","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1007\/s13346-022-01233-3","article-title":"Nanomaterials for antigen-specific immune tolerance therapy","volume":"13","author":"Park","year":"2023","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.jconrel.2025.02.029_bb0535","doi-asserted-by":"crossref","first-page":"5229","DOI":"10.2147\/IJN.S210546","article-title":"Induction of antigen-specific immune tolerance using biodegradable nanoparticles containing antigen and dexamethasone","volume":"14","author":"Kim","year":"2019","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2025.02.029_bb0540","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/nri.2017.1","article-title":"Immune regulation by glucocorticoids","volume":"17","author":"Cain","year":"2017","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2025.02.029_bb0545","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.cytogfr.2010.09.002","article-title":"Biology of interleukin-10","volume":"21","author":"Sabat","year":"2010","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.jconrel.2025.02.029_bb0550","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aat1482","article-title":"Revisiting IL-2: biology and therapeutic prospects","volume":"3","author":"Abbas","year":"2018","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.jconrel.2025.02.029_bb0555","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s10753-016-0476-2","article-title":"Immunomodulatory effects of adjuvants CPG, MPLA, and BCG on the Derp2-induced acute asthma at early life in an animal model of BALB\/c mice","volume":"40","author":"Mohammadi-Shahrokhi","year":"2017","journal-title":"Inflammation"},{"key":"10.1016\/j.jconrel.2025.02.029_bb0560","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.imlet.2013.12.011","article-title":"Perspectives in vaccine adjuvants for allergen-specific immunotherapy","volume":"161","author":"Fil\u00ec","year":"2014","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.jconrel.2025.02.029_bb0565","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/nri.2017.111","article-title":"The hygiene hypothesis in autoimmunity: the role of pathogens and commensals","volume":"18","author":"Bach","year":"2018","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2025.02.029_bb0570","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/836485","article-title":"The effects of TLR activation on T-cell development and differentiation","volume":"2012","author":"Jin","year":"2012","journal-title":"Clin. Dev. Immunol."},{"key":"10.1016\/j.jconrel.2025.02.029_bb0575","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1038\/nm.2754","article-title":"Therapies for allergic inflammation: refining strategies to induce tolerance","volume":"18","author":"Akdis","year":"2012","journal-title":"Nat. Med."},{"key":"10.1016\/j.jconrel.2025.02.029_bb0580","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s40413-015-0063-2","article-title":"Mechanisms of allergen-specific immunotherapy and immune tolerance to allergens","volume":"8","author":"Akdis","year":"2015","journal-title":"World Allergy Organ J"},{"key":"10.1016\/j.jconrel.2025.02.029_bb0585","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1016\/j.jaci.2017.08.025","article-title":"Advances and highlights in allergen immunotherapy: on the way to sustained clinical and immunologic tolerance","volume":"140","author":"Berings","year":"2017","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.jconrel.2025.02.029_bb0590","doi-asserted-by":"crossref","first-page":"4289","DOI":"10.3390\/ijms24054289","article-title":"Chitosan nanoparticles as Oral drug carriers","volume":"5","author":"Guadarrama-Escobar","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jconrel.2025.02.029_bb0595","first-page":"765","article-title":"Recent advances of chitosan nanoparticles as drug carriers","volume":"6","author":"Wang","year":"2011","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2025.02.029_bb0600","doi-asserted-by":"crossref","DOI":"10.1016\/j.ntm.2024.100040","article-title":"Chitosan nanoparticle delivery systems: an effective approach to enhancing efficacy and safety of anticancer drugs","volume":"3","author":"Grewal","year":"2024","journal-title":"Nano TransMed"},{"key":"10.1016\/j.jconrel.2025.02.029_bb0605","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.122570","article-title":"Nanocarriers based novel and effective drug delivery system","volume":"632","author":"Khizar","year":"2023","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2025.02.029_bb0610","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.3390\/nano10071403","article-title":"Polymeric nanoparticles for drug delivery: recent developments and future prospects","volume":"7","author":"Begines","year":"2020","journal-title":"Nanomaterials"},{"key":"10.1016\/j.jconrel.2025.02.029_bb0615","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0168-3659(94)90039-6","article-title":"Liposomes and niosomes as topical drug carriers: dermal and transdermal drug delivery","volume":"30","author":"Schreier","year":"1994","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.02.029_bb0620","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1211\/jpp.58.4.0001","article-title":"Can drug-bearing liposomes penetrate intact skin?","volume":"58","author":"El Maghraby","year":"2006","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.jconrel.2025.02.029_bb0625","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2020.113642","article-title":"Analytical characterization of liposomes and other lipid nanoparticles for drug delivery","volume":"192","author":"Fan","year":"2021","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jconrel.2025.02.029_bb0630","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1080\/10837450.2022.2084554","article-title":"Solid lipid nanoparticles and nanostructured lipid carriers: a review of the methods of manufacture and routes of administration","volume":"27","author":"Akbari","year":"2022","journal-title":"Pharm. Dev. Technol."},{"key":"10.1016\/j.jconrel.2025.02.029_bb0635","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1021\/acs.accounts.1c00544","article-title":"Chemistry of lipid nanoparticles for RNA delivery","volume":"55","author":"Eygeris","year":"2022","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.jconrel.2025.02.029_bb0640","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jconrel.2017.03.008","article-title":"Nanoemulsion: concepts, development and applications in drug delivery","volume":"252","author":"Singh","year":"2017","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.02.029_bb0645","doi-asserted-by":"crossref","first-page":"3271","DOI":"10.2147\/DDDT.S264648","article-title":"Potential of nanoparticles as permeation enhancers and targeted delivery options for skin: advantages and disadvantages","volume":"14","author":"Ghasemiyeh","year":"2020","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.jconrel.2025.02.029_bb0650","doi-asserted-by":"crossref","first-page":"5046","DOI":"10.1039\/D0NA00478B","article-title":"Biomedical nanomaterials for immunological applications: ongoing research and clinical trials","volume":"2","author":"Lenders","year":"2020","journal-title":"Nanoscale Adv."},{"key":"10.1016\/j.jconrel.2025.02.029_bb0655","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1002\/adma.200901263","article-title":"Recent progress on silica coating of nanoparticles and related nanomaterials","volume":"22","author":"Guerrero-Mart\u00ednez","year":"2010","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2025.02.029_bb0660","article-title":"Skin biomechanics: breaking the dermal barriers with microneedles","volume":"1","author":"Ali","year":"2022","journal-title":"Nano Trans Med."},{"key":"10.1016\/j.jconrel.2025.02.029_bb0665","doi-asserted-by":"crossref","first-page":"3480","DOI":"10.1039\/C9TB00557A","article-title":"Recent advances in gold nanoparticles for biomedical applications: from hybrid structures to multi-functionality","volume":"7","author":"Jeong","year":"2019","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.jconrel.2025.02.029_bb0670","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.actbio.2018.12.045","article-title":"Exosomes: the next generation of endogenous nanomaterials for advanced drug delivery and therapy","volume":"86","author":"Liao","year":"2019","journal-title":"Acta Biomater."},{"key":"10.1016\/j.jconrel.2025.02.029_bb0675","doi-asserted-by":"crossref","first-page":"3372","DOI":"10.1007\/s12035-017-0582-7","article-title":"Exosomes and their application in biomedical field: difficulties and advantages","volume":"55","author":"Rezaie","year":"2018","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.jconrel.2025.02.029_bb0680","article-title":"Recent advances in macrophage-derived exosomes as delivery vehicles","volume":"1","author":"Wang","year":"2022","journal-title":"Nano Trans Med."},{"key":"10.1016\/j.jconrel.2025.02.029_bb0685","doi-asserted-by":"crossref","DOI":"10.1002\/EXP.20230139","article-title":"Unveiling the promise: exosomes as game-changers in anti-infective therapy","volume":"4","author":"Chavda","year":"2024","journal-title":"Exploration"},{"key":"10.1016\/j.jconrel.2025.02.029_bb0690","doi-asserted-by":"crossref","first-page":"6389","DOI":"10.1038\/s41598-022-10448-w","article-title":"Association of rhinitis with asthma prevalence and severity","volume":"12","author":"Acevedo-Prado","year":"2022","journal-title":"Sci. Rep."},{"issue":"Suppl. 2","key":"10.1016\/j.jconrel.2025.02.029_bb0695","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1136\/thorax.55.suppl_2.S26","article-title":"United airways disease: therapeutic aspects","volume":"55","author":"Passalacqua","year":"2000","journal-title":"Thorax"},{"key":"10.1016\/j.jconrel.2025.02.029_bb0700","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s00281-020-00785-1","article-title":"Asthma epidemiology and risk factors","volume":"42","author":"Stern","year":"2020","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.jconrel.2025.02.029_bb0705","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0091-6749(99)70370-2","article-title":"Perennial rhinitis: an independent risk factor for asthma in nonatopic subjects: results from the European Community respiratory health survey","volume":"104","author":"Leynaert","year":"1999","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.jconrel.2025.02.029_bb0710","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/0091-6749(92)90130-T","article-title":"The association of individual allergen reactivity with respiratory disease in a national sample: data from the second National Health and nutrition examination survey, 1976-80 (NHANES II)","volume":"90","author":"Gergen","year":"1992","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.jconrel.2025.02.029_bb0715","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/j.1398-9995.2005.00717.x","article-title":"Rhinitis is an independent risk factor for developing cough apart from colds among adults","volume":"60","author":"Guerra","year":"2005","journal-title":"Allergy"},{"key":"10.1016\/j.jconrel.2025.02.029_bb0720","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1080\/1744666X.2022.2089654","article-title":"Comorbid allergic rhinitis and asthma: important clinical considerations","volume":"18","author":"Nappi","year":"2022","journal-title":"Expert Rev. Clin. Immunol."},{"key":"10.1016\/j.jconrel.2025.02.029_bb0725","article-title":"Intranasal corticosteroids for asthma control in people with coexisting asthma and rhinitis","volume":"2003","author":"Taramarcaz","year":"2003","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.jconrel.2025.02.029_bb0730","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0091-6749(85)90701-8","article-title":"Allergenicity, immunogenicity, and safety of immunotherapy with various molecular weight ranges of polymerized ragweed","volume":"76","author":"Grammer","year":"1985","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.jconrel.2025.02.029_bb0735","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/0091-6749(87)90013-3","article-title":"Double-blind, placebo-controlled immunotherapy with mixed grass-pollen allergoids. I. Rush immunotherapy with allergoids and standardized orchard grass-pollen extract","volume":"80","author":"Bousquet","year":"1987","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.jconrel.2025.02.029_bb0740","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/0091-6749(90)90160-6","article-title":"Double-blind, placebo-controlled immunotherapy with mixed grass-pollen allergoids. IV. Comparison of the safety and efficacy of two dosages of a high-molecular-weight allergoid","volume":"85","author":"Bousquet","year":"1990","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.jconrel.2025.02.029_bb0745","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1111\/j.1398-9995.2005.00790.x","article-title":"Efficacy and safety of preseasonal-specific immunotherapy with an aluminium-adsorbed six-grass pollen allergoid","volume":"60","author":"Corrigan","year":"2005","journal-title":"Allergy"},{"key":"10.1016\/j.jconrel.2025.02.029_bb0750","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/j.1398-9995.2011.02736.x","article-title":"A randomized placebo-controlled trial of rush preseasonal depigmented polymerized grass pollen immunotherapy","volume":"67","author":"Pfaar","year":"2012","journal-title":"Allergy"},{"key":"10.1016\/j.jconrel.2025.02.029_bb0755","doi-asserted-by":"crossref","first-page":"e104","DOI":"10.2500\/ajra.2010.24.3508","article-title":"Efficacy and safety of a glutaraldehyde-modified house dust mite extract in allergic rhinitis","volume":"24","author":"Riechelmann","year":"2010","journal-title":"Am. J. Rhinol. Allergy"},{"key":"10.1016\/j.jconrel.2025.02.029_bb0760","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1007\/s12016-018-8693-0","article-title":"The role of dust mites in allergy","volume":"57","author":"Miller","year":"2019","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.jconrel.2025.02.029_bb0765","doi-asserted-by":"crossref","first-page":"3616","DOI":"10.21037\/jtd.2019.06.35","article-title":"House dust mite subcutaneous immunotherapy in Chinese patients with allergic asthma and rhinitis","volume":"11","author":"Feng","year":"2019","journal-title":"J. Thorac. Dis."},{"key":"10.1016\/j.jconrel.2025.02.029_bb0770","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jaci.2014.12.1938","article-title":"Prevention of allergic asthma through Der p 2 peptide vaccination","volume":"136","author":"Bouchaud","year":"2015","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.jconrel.2025.02.029_bb0775","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jconrel.2014.12.040","article-title":"Nasal delivery of Japanese cedar pollen Cryj1 by using self-gelling immunostimulatory DNA for effective induction of immune responses in mice","volume":"200","author":"Ishii-Mizuno","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.02.029_bb0780","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.1080\/21645515.2017.1329070","article-title":"Safety and long-term immunological effects of CryJ2-LAMP plasmid vaccine in Japanese red cedar atopic subjects: a phase I study","volume":"13","author":"Su","year":"2017","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.jconrel.2025.02.029_bb0785","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1111\/all.12326","article-title":"Epicutaneous immune modulation with Bet v 1 plus R848 suppresses allergic asthma in a murine model","volume":"69","author":"Siebeneicher","year":"2014","journal-title":"Allergy"},{"key":"10.1016\/j.jconrel.2025.02.029_bb0790","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2010.04.039","article-title":"Phl p 5 resorption in human oral mucosa leads to dose-dependent and time-dependent allergen binding by oral mucosal Langerhans cells, attenuates their maturation, and enhances their migratory and TGF-beta1 and IL-10-producing properties","volume":"126","author":"Allam","year":"2010","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.jconrel.2025.02.029_bb0795","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.983621","article-title":"A recombinant Artemisia vulgaris pollen adjuvanted art v 1 protein-based vaccine treats allergic rhinitis and bronchial asthma using pre- and co-seasonal ultrashort immunotherapy regimens in sensitized mice","volume":"13","author":"Babayeva","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2025.02.029_bb0800","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1021\/acs.molpharmaceut.8b01093","article-title":"Effects of localization of antigen proteins in antigen-loaded exosomes on efficiency of antigen presentation","volume":"16","author":"Arima","year":"2019","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2025.02.029_bb0805","doi-asserted-by":"crossref","DOI":"10.1016\/j.imbio.2023.152361","article-title":"Immune response modulation by allergen loaded into mesenchymal stem cell-derived exosomes as an effective carrier through sublingual immunotherapy","volume":"228","author":"Dehnavi","year":"2023","journal-title":"Immunobiology"},{"key":"10.1016\/j.jconrel.2025.02.029_bb0810","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.110405","article-title":"Sublingual prophylactic administration of OVA-loaded MSC-derived exosomes to prevent allergic sensitization","volume":"120","author":"Asadirad","year":"2023","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.jconrel.2025.02.029_bb0815","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1186\/s13287-024-04099-z","article-title":"Immunomodulatory features of MSC-derived exosomes decorated with DC-specific aptamer for improving sublingual immunotherapy in allergic mouse model","volume":"15","author":"Sadeghi","year":"2024","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.jconrel.2025.02.029_bb0820","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/nri2858","article-title":"Antigen-presenting cell function in the tolerogenic liver environment","volume":"10","author":"Thomson","year":"2010","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2025.02.029_bb0825","first-page":"R1217","article-title":"The scavenger endothelial cell: a new player in homeostasis and immunity","volume":"303","author":"S\u00f8rensen","year":"2012","journal-title":"Am. J. Phys. Regul. Integr. Comp. Phys."},{"key":"10.1016\/j.jconrel.2025.02.029_bb0830","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1016\/j.jhep.2015.01.006","article-title":"Nanoparticle-based autoantigen delivery to Treg-inducing liver sinusoidal endothelial cells enables control of autoimmunity in mice","volume":"62","author":"Carambia","year":"2015","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jconrel.2025.02.029_bb0835","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1111\/pai.12964","article-title":"DNA and mRNA vaccination against allergies","volume":"29","author":"Scheiblhofer","year":"2018","journal-title":"Pediatr. Allergy Immunol."},{"key":"10.1016\/j.jconrel.2025.02.029_bb0840","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.jaci.2006.04.048","article-title":"Immunization with a low-dose replicon DNA vaccine encoding Phl p 5 effectively prevents allergic sensitization","volume":"118","author":"Gabler","year":"2006","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.jconrel.2025.02.029_bb0845","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/4857869","article-title":"CryJ-LAMP DNA vaccines for Japanese red cedar allergy induce robust Th1-type immune responses in murine model","volume":"2016","author":"Su","year":"2016","journal-title":"J Immunol Res"},{"key":"10.1016\/j.jconrel.2025.02.029_bb0850","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.1080\/21645515.2017.1329070","article-title":"Safety and long-term immunological effects of CryJ2-LAMP plasmid vaccine in Japanese red cedar atopic subjects: a phase I study","volume":"13","author":"Su","year":"2017","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.jconrel.2025.02.029_bb0855","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1126\/science.aac6623","article-title":"Farm dust and endotoxin protect against allergy through A20 induction in lung epithelial cells","volume":"349","author":"Schuijs","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2025.02.029_bb0860","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/797421","article-title":"Prophylactic mRNA vaccination against allergy confers long-term memory responses and persistent protection in mice","volume":"2015","author":"Hattinger","year":"2015","journal-title":"J Immunol Res"},{"key":"10.1016\/j.jconrel.2025.02.029_bb0865","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jconrel.2023.03.041","article-title":"Spleen-selective co-delivery of mRNA and TLR4 agonist-loaded LNPs for synergistic immunostimulation and Th1 immune responses","volume":"357","author":"Pan","year":"2023","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.02.029_bb0870","first-page":"11","article-title":"Update in the mechanisms of allergen-specific immunotheraphy, allergy asthma","volume":"3","author":"Akkoc","year":"2011","journal-title":"Immunol. Res."},{"key":"10.1016\/j.jconrel.2025.02.029_bb0875","doi-asserted-by":"crossref","first-page":"17098","DOI":"10.1038\/nrdp.2017.98","article-title":"Food allergy","volume":"4","author":"Renz","year":"2018","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.jconrel.2025.02.029_bb0880","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s11882-020-0898-7","article-title":"Epidemiology and burden of food allergy","volume":"20","author":"Warren","year":"2020","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.1016\/j.jconrel.2025.02.029_bb0885","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jaci.2017.11.003","article-title":"Food allergy: a review and update on epidemiology, pathogenesis, diagnosis, prevention, and management","volume":"141","author":"Sicherer","year":"2018","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.jconrel.2025.02.029_bb0890","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.imlet.2020.12.011","article-title":"Integrin \u03b1v\u03b26 cooperates with resiquimod to restore antigen-specific immune tolerance in airway allergy","volume":"230","author":"Ma","year":"2021","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.jconrel.2025.02.029_bb0895","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1046\/j.1365-2222.1999.00612.x","article-title":"Allergy to bovine beta-lactoglobulin: specificity of human IgE to tryptic peptides","volume":"29","author":"S\u00e9lo","year":"1999","journal-title":"Clin. Exp. Allergy"},{"key":"10.1016\/j.jconrel.2025.02.029_bb0900","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.jaci.2013.12.1040","article-title":"State of the art on food allergen immunotherapy: oral, sublingual, and epicutaneous","volume":"133","author":"Jones","year":"2014","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.jconrel.2025.02.029_bb0905","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1080\/1744666X.2019.1554432","article-title":"Allergen immunotherapy for food allergy from the Asian perspective: key challenges and opportunities","volume":"15","author":"Leung","year":"2019","journal-title":"Expert Rev. Clin. Immunol."},{"key":"10.1016\/j.jconrel.2025.02.029_bb0910","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20184656","article-title":"Modulating shrimp tropomyosin-mediated allergy: Hypoallergen DNA vaccines induce regulatory T cells to reduce hypersensitivity in mouse model","volume":"20","author":"Wai","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jconrel.2025.02.029_bb0915","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.109394","article-title":"Lit-LAMP-DNA-vaccine for shrimp allergy prevents anaphylactic symptoms in a murine model","volume":"113","author":"Kubo","year":"2022","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.jconrel.2025.02.029_bb0920","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1097\/ACI.0000000000000204","article-title":"Epidemiology of allergic conjunctivitis: clinical appearance and treatment patterns in a population-based study","volume":"15","author":"Leonardi","year":"2015","journal-title":"Curr. Opin. Allergy Clin. Immunol."},{"key":"10.1016\/j.jconrel.2025.02.029_bb0925","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0140-6736(20)31286-1","article-title":"Atopic dermatitis","volume":"396","author":"Langan","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.jconrel.2025.02.029_bb0930","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.alit.2020.06.004","article-title":"Epidemiological aspects of allergic conjunctivitis","volume":"69","author":"Miyazaki","year":"2020","journal-title":"Allergol. Int."},{"key":"10.1016\/j.jconrel.2025.02.029_bb0935","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/all.12270","article-title":"New insights into the epidemiology of childhood atopic dermatitis","volume":"69","author":"Flohr","year":"2014","journal-title":"Allergy"},{"key":"10.1016\/j.jconrel.2025.02.029_bb0940","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.mehy.2013.08.007","article-title":"Topical tacrolimus nanoemulsion, a promising therapeutic approach for uveitis","volume":"81","author":"Garg","year":"2013","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.jconrel.2025.02.029_bb0945","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.biopha.2017.07.110","article-title":"Poly (d, l-lactide-co-glycolide) nanoparticles for sustained release of tacrolimus in rabbit eyes","volume":"94","author":"Kalam","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.jconrel.2025.02.029_bb0950","doi-asserted-by":"crossref","DOI":"10.1088\/1361-6528\/aafe36","article-title":"Evaluation of controlled-release triamcinolone acetonide-loaded mPEG-PLGA nanoparticles in treating experimental autoimmune uveitis","volume":"30","author":"Guo","year":"2019","journal-title":"Nanotechnology"},{"key":"10.1016\/j.jconrel.2025.02.029_bb0955","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.ijpharm.2008.07.028","article-title":"Cyclosporine a loaded SLNs: evaluation of cellular uptake and corneal cytotoxicity","volume":"364","author":"Gokce","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2025.02.029_bb0960","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.colsurfb.2010.07.029","article-title":"Design and ocular tolerance of flurbiprofen loaded ultrasound-engineered NLC","volume":"81","author":"Gonzalez-Mira","year":"2010","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.jconrel.2025.02.029_bb0965","doi-asserted-by":"crossref","first-page":"4436","DOI":"10.1021\/acsapm.1c00021","article-title":"Hydrogels containing budesonide-loaded nanoparticles to facilitate percutaneous absorption for atopic dermatitis treatment applications","volume":"3","author":"Campos","year":"2021","journal-title":"ACS Appl. Polym. Mater."},{"key":"10.1016\/j.jconrel.2025.02.029_bb0970","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s13346-017-0439-7","article-title":"Potential treatment of atopic dermatitis: tolerability and safety of cream containing nanoparticles loaded with hydrocortisone and hydroxytyrosol in human subjects","volume":"9","author":"Siddique","year":"2019","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.jconrel.2025.02.029_bb0975","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.121079","article-title":"Tacrolimus encapsulated mesoporous silica nanoparticles embedded hydrogel for the treatment of atopic dermatitis","volume":"608","author":"Parekh","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2025.02.029_bb0980","doi-asserted-by":"crossref","first-page":"221","DOI":"10.4168\/aair.2015.7.3.221","article-title":"Specific immunotherapy in atopic dermatitis","volume":"7","author":"Lee","year":"2015","journal-title":"Allergy, Asthma Immunol. Res."},{"key":"10.1016\/j.jconrel.2025.02.029_bb0985","article-title":"Therapeutic DNA vaccine attenuates itching and allergic inflammation in mice with established biting midge allergy","volume":"15","author":"Lee","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2025.02.029_bb0990","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1097\/ACI.0b013e3282f1d66c","article-title":"Allergen specific immunotherapy for atopic dermatitis","volume":"7","author":"Novak","year":"2007","journal-title":"Curr. Opin. Allergy Clin. Immunol."},{"key":"10.1016\/j.jconrel.2025.02.029_bb0995","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1186\/s13287-018-0939-5","article-title":"Exosomes derived from human adipose tissue-derived mesenchymal stem cells alleviate atopic dermatitis","volume":"9","author":"Cho","year":"2018","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.jconrel.2025.02.029_bb1000","doi-asserted-by":"crossref","first-page":"385","DOI":"10.2147\/JAA.S242058","article-title":"Latex allergy: current status and future perspectives","volume":"13","author":"Nucera","year":"2020","journal-title":"J. Asthma Allergy"},{"key":"10.1016\/j.jconrel.2025.02.029_bb1005","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1067\/mai.2003.164","article-title":"In vivo sensitization to purified Hevea brasiliensis proteins in health care workers sensitized to natural rubber latex","volume":"111","author":"Bernstein","year":"2003","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.jconrel.2025.02.029_bb1010","doi-asserted-by":"crossref","first-page":"2721","DOI":"10.4049\/jimmunol.155.5.2721","article-title":"Characterization of a major latex allergen associated with hypersensitivity in spina bifida patients","volume":"155","author":"Lu","year":"1995","journal-title":"J. Immunol. (Baltimore, Md.: 1950)"},{"key":"10.1016\/j.jconrel.2025.02.029_bb1015","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1159\/000095463","article-title":"Specific immunotherapy with standardized latex extract versus placebo in latex-allergic patients","volume":"141","author":"Tabar","year":"2006","journal-title":"Int. Arch. Allergy Immunol."},{"key":"10.1016\/j.jconrel.2025.02.029_bb1020","doi-asserted-by":"crossref","first-page":"145","DOI":"10.5114\/ada.2018.75235","article-title":"Latex immunotherapy: evidence of effectiveness","volume":"35","author":"Nucera","year":"2018","journal-title":"Postepy Dermatol. Alergol."},{"key":"10.1016\/j.jconrel.2025.02.029_bb1025","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/s41572-022-00389-z","article-title":"Urticaria","volume":"8","author":"Kolkhir","year":"2022","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.jconrel.2025.02.029_bb1030","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s13223-018-0288-z","article-title":"Urticaria and angioedema","volume":"14","author":"Kanani","year":"2018","journal-title":"Allergy, Asthma Clin. Immunol."},{"key":"10.1016\/j.jconrel.2025.02.029_bb1035","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1111\/all.15090","article-title":"The international guideline for the definition, classification, diagnosis, and management of urticaria","volume":"77","author":"Zuberbier","year":"2022","journal-title":"Allergy"},{"key":"10.1016\/j.jconrel.2025.02.029_bb1040","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1111\/j.1365-2222.2008.03031.x","article-title":"Heterogeneity of commercial timothy grass pollen extracts","volume":"38","author":"Focke","year":"2008","journal-title":"Clin. Exp. Allergy"},{"key":"10.1016\/j.jconrel.2025.02.029_bb1045","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.jaci.2015.12.1299","article-title":"Vaccine development for allergen-specific immunotherapy based on recombinant allergens and synthetic allergen peptides: lessons from the past and novel mechanisms of action for the future","volume":"137","author":"Valenta","year":"2016","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.jconrel.2025.02.029_bb1050","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/j.1365-2222.2009.03443.x","article-title":"Developments in allergen-specific immunotherapy: from allergen extracts to allergy vaccines bypassing allergen-specific immunoglobulin E and T cell reactivity","volume":"40","author":"Focke","year":"2010","journal-title":"Clin. Exp. Allergy"},{"key":"10.1016\/j.jconrel.2025.02.029_bb1055","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/j.1365-2796.2012.02556.x","article-title":"Allergen-specific immunotherapy: from therapeutic vaccines to prophylactic approaches","volume":"272","author":"Valenta","year":"2012","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.jconrel.2025.02.029_bb1060","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1586\/erv.11.168","article-title":"mRNA vaccination as a safe approach for specific protection from type I allergy","volume":"11","author":"Weiss","year":"2012","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.jconrel.2025.02.029_bb1065","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.ymeth.2003.08.014","article-title":"DNA vaccines for allergy treatment","volume":"32","author":"Hartl","year":"2004","journal-title":"Methods"},{"key":"10.1016\/j.jconrel.2025.02.029_bb1070","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.864403","article-title":"Nanoparticles for inducing antigen-specific T cell tolerance in autoimmune diseases","volume":"13","author":"Benne","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2025.02.029_bb1075","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.3389\/fimmu.2020.02194","article-title":"Induction of antigen-specific tolerance in T cell mediated diseases","volume":"11","author":"Passerini","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2025.02.029_bb1080","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/cr.2015.9","article-title":"Cationic nanocarriers induce cell necrosis through impairment of Na(+)\/K(+)-ATPase and cause subsequent inflammatory response","volume":"25","author":"Wei","year":"2015","journal-title":"Cell Res."},{"key":"10.1016\/j.jconrel.2025.02.029_bb1085","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.jconrel.2021.11.042","article-title":"Anti-PEG antibodies compromise the integrity of PEGylated lipid-based nanoparticles via complement","volume":"341","author":"Estap\u00e9 Senti","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.02.029_bb1090","doi-asserted-by":"crossref","first-page":"3271","DOI":"10.2147\/DDDT.S264648","article-title":"Potential of nanoparticles as permeation enhancers and targeted delivery options for skin: advantages and disadvantages","author":"Ghasemiyeh","year":"2020","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.jconrel.2025.02.029_bb1095","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/nyas.13461","article-title":"Complexity of intravenous iron nanoparticle formulations: implications for bioequivalence evaluation","volume":"1407","author":"Pai","year":"2017","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.jconrel.2025.02.029_bb1100","doi-asserted-by":"crossref","first-page":"247","DOI":"10.3109\/09687688.2010.522203","article-title":"Interaction of nanoparticles and cell-penetrating peptides with skin for transdermal drug delivery","volume":"27","author":"Desai","year":"2010","journal-title":"Mol. Membr. Biol."},{"key":"10.1016\/j.jconrel.2025.02.029_bb1105","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1080\/17425247.2018.1429401","article-title":"Lipid nanoparticles for intranasal administration: application to nose-to-brain delivery","volume":"15","author":"Battaglia","year":"2018","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.jconrel.2025.02.029_bb1110","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2019.118813","article-title":"Nasal route for vaccine and drug delivery: features and current opportunities","volume":"572","author":"Lobaina Mato","year":"2019","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2025.02.029_bb1115","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.3389\/fphar.2019.01328","article-title":"Advances in nanoparticulate drug delivery approaches for sublingual and buccal administration","volume":"10","author":"Hua","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jconrel.2025.02.029_bb1120","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.cocis.2010.12.005","article-title":"Fate of polymeric nanocarriers for oral drug delivery","volume":"16","author":"Plapied","year":"2011","journal-title":"Curr. Opin. Colloid Interface Sci."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365925001427?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365925001427?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T17:53:27Z","timestamp":1770141207000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365925001427"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":224,"alternative-id":["S0168365925001427"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.02.029","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tolerogenic nanovaccines for the treatment of type I allergic diseases","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.02.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}